Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on March 23, 2009

Circulation. 2009
Published online before print March 23, 2009, doi: 10.1161/CIRCULATIONAHA.108.800565
A more recent version of this article appeared on April 7, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/13/1776    most recent
CIRCULATIONAHA.108.800565v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Dai, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Dai, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Acute myocardial infarction
Right arrowRelated Article

Submitted on June 20, 2008
Accepted on February 2, 2009

Collagen-Targeting Vascular Endothelial Growth Factor Improves Cardiac Performance After Myocardial Infarction

Jing Zhang BS, Liang Ding MD, Yannan Zhao BS, Wenjie Sun MS, Bing Chen PhD, Hang Lin PhD, Xia Wang MS, Lujie Zhang MD, Biao Xu MD, PhD*, and Jianwu Dai PhD*

From Key Laboratory of Molecular Developmental Biology (J.Z., Y.Z., W.S., B.C., H.L., X.W., J.D.), Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China; Graduate School, Chinese Academy of Sciences (J.Z., Y.Z.), Beijing, China; and Department of Cardiology (L.D., L.Z., B.X.), Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.

* To whom correspondence should be addressed. E-mail: xubiao{at}medmail.com.cn or jwdai{at}genetics.ac.cn.

Background—Vascular endothelial growth factor (VEGF) is an important active protein for the induction of angiogenesis and improvement in cardiac function after myocardial ischemia; however, the lack of a delivery system targeted to the injured myocardium reduces the local therapeutic efficacy of VEGF and increases its possible adverse effects.

Methods and Results—We produced a fusion protein (CBD-VEGF) consisting of VEGF and a collagen-binding domain (CBD). The fusion protein specifically bound to type I collagen in vitro. In addition, CBD-VEGF promoted human umbilical vein endothelial cell proliferation after binding to collagen, which indicates that it retained both growth factor activity and collagen-binding ability. When implanted subcutaneously in rats, collagen membranes loaded with CBD-VEGF were significantly vascularized. After it was injected into rats with acute myocardial infarction, CBD-VEGF was largely retained in the cardiac extracellular matrix, in which collagen I was rich. Four weeks after VEGF or CBD-VEGF was injected into the infarct border zone, cardiac function detected by echocardiography and hemodynamics was preserved in the CBD-VEGF group. Administration of CBD-VEGF also induced reduction of scar size, whereas native VEGF did not have these effects. In addition, a significant increase in the number of capillary vessels in infarcted hearts was found in the CBD-VEGF group.

Conclusions—The injection of CBD-VEGF improved cardiac function in rats with induced acute myocardial infarction. This could potentially provide a new treatment option for myocardial infarction.


Key words: vascular endothelial growth factors • collagen • angiogenesis • myocardial infarction


Related Article:

Clinical Summaries
Circulation 2009 119: 1691-1693. [Extract] [Full Text]